|SUBJECT:||M.S. Thesis Presentation|
|TIME:||Monday, July 16, 2018, 1:00 p.m.|
|PLACE:||U.A. Whitaker Building, 3115|
|TITLE:||Development of a Device for Subconjunctival Drug Delivery|
|COMMITTEE:||Dr. C. Ross Ethier, Chair (BME, GT)
Dr. Hans E. Grossniklaus, MD (OPHTH, Emory)
Dr. Frank L. Hammond III (ME, GT)
Subconjunctival (SC) injections have been widely used by ophthalmologists to locally administer various therapeutic agents to the eye (e.g., steroids, antibiotics, and anesthetics). Periocular delivery methods are often more effective than commonly prescribed topical eye drops, improving drug pharmacokinetics and circumventing patient noncompliance. However, the practice of SC delivery is limited by current techniques, which are based on century-old technology and require surgically-trained experts.